# Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

> **NCT00698191** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Nanjing Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Refractory Systemic Lupus Erythematosus

## Interventions

- **BIOLOGICAL:** Allogeneic MSC (AlloMSC)

## Key facts

- **NCT ID:** NCT00698191
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-03
- **Primary completion:** 2011-12
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2008-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698191, "Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00698191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*